4- (3-aminopyrazole) pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer

Details for Australian Patent Application No. 2006307657 (hide)

Owner AstraZeneca AB

Inventors Wang, Bin; Guan, Huiping; Ioannidis, Stephanos; Kan, Ying; Zhang, Hai-Jun; Su, Mei; Wang, Tao; Peng, Bo; Feng, Xiaomei

Agent Davies Collison Cave

Pub. Number AU-B-2006307657

PCT Pub. Number WO2007/049041

Priority 60/803,061 24.05.06 US; 60/731,299 28.10.05 US

Filing date 26 October 2006

Wipo publication date 3 May 2007

Acceptance publication date 28 October 2010

International Classifications

C07D 403/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

15 May 2008 PCT application entered the National Phase

  PCT publication WO2007/049041 Priority application(s): WO2007/049041

28 October 2010 Application Accepted

  Published as AU-B-2006307657

24 February 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006307667-Improved filter element

2006307653-Baking mould